Anbio Biotechnology (NNNN)
Last updated: 2026-10-20 15:19:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Anbio Biotechnology (NNNN) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $3.91, with a market capitalization of $137.38M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.09 to $44.73. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$137.38M | |
$3.43 | |
$55.65 | |
$3.09 | |
$3.27 | |
153.33K | |
149.99K | |
-- | |
$44.73 | |
$3.09 | |
-- | |
-- |
Anbio Biotechnology (NNNN) Stock Price Today
Anbio Biotechnology (NNNN) is currently trading at $3.91 as of 2026-10-20 15:02:03, up 19.57% ($0.64) from the previous close of $3.27
During today's regular trading session, NNNN has traded between $3.09 and $55.65, with a trading volume of 153.33K shares. The current price is near the lower end of today's range.
Anbio Biotechnology (NNNN) 7-Day Stock Price Change
Over the past seven days, Anbio Biotechnology (NNNN) moved from $4.66 to $3.91, representing a decline of 16.09% ($0.75).
The stock traded between $3.09 and $5.16 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 48.11 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
NNNN 52-Week Price Position
Position in Range: 2.0%
NNNN is currently trading at $3.91, placing it 2.0% of the way from its 52-week low of $3.09 to its 52-week high of $44.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Anbio Biotechnology (NNNN)?
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Anbio Biotechnology Information
| Employees | 27 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Anbio Biotechnology (NNNN) Stock on MEXC
Eligible investors can buy real shares of Anbio Biotechnology (NNNN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Anbio Biotechnology (NNNN) stock price today?
2.Is NNNN stock going up or down today?
3.What is NNNN pre-market price?
4.What is NNNN after-hours price?
5.Is NNNN stock trading now?
6.Where does NNNN sit relative to its 52-week high and low?
7.What sector is Anbio Biotechnology in?
8.What is Anbio Biotechnology's market capitalization and where is it listed?
9.How is NNNN valued in terms of P/E ratio and EPS?
10.Does Anbio Biotechnology pay a dividend?
Explore More US Stocks
Search Stocks
NNNN Stock Calculator
Estimate the value between NNNN shares and USD.
NNNN Shares to USD
1.00 NNNN shares = 3.91 USD
Calculations are estimates based on the latest available price and are for reference only.


